Xiong HR - Search Results

1

[Pharmacokinetics and relative bioavailability of neostigmine bromide sustained-release tablets].

Xiong HR, Tan QY, Liu BL, Luo W, Zhang JQ. Xiong HR, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2011 Sep;42(5):657-60. Sichuan Da Xue Xue Bao Yi Xue Ban. 2011. PMID: 22007493 Chinese.

2

[Correlation between in vitro release and in vivo absorption of sustained-releasing tablets of neostigmine bromide].

Luo W, Tan QY, Xiong HR, Zhao CJ, Zhang JQ. Luo W, et al. Among authors: xiong hr. Sichuan Da Xue Xue Bao Yi Xue Ban. 2013 Jan;44(1):80-3. Sichuan Da Xue Xue Bao Yi Xue Ban. 2013. PMID: 23600216 Chinese.

3

Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability.

Tan Q, Liu S, Chen X, Wu M, Wang H, Yin H, He D, Xiong H, Zhang J. Tan Q, et al. AAPS PharmSciTech. 2012 Jun;13(2):534-47. doi: 10.1208/s12249-012-9772-9. Epub 2012 Mar 28. AAPS PharmSciTech. 2012. PMID: 22454136 Free PMC article.

4

[The Pharmacokinetics and Pharmacodynamics of Intravenous Uricase Multivesicular Liposomes].

Deng X, He D, Xiong HR, Zhou YL, Zhang JQ. Deng X, et al. Among authors: xiong hr. Sichuan Da Xue Xue Bao Yi Xue Ban. 2015 Sep;46(5):688-91. Sichuan Da Xue Xue Bao Yi Xue Ban. 2015. PMID: 26619536 Chinese.

5

Azithromycin cationic non-lecithoid nano/microparticles improve bioavailability and targeting efficiency.

Zhong M, Feng Y, Liao H, Hu X, Wan S, Zhu B, Zhang M, Xiong H, Zhou Y, Zhang J. Zhong M, et al. Pharm Res. 2014 Oct;31(10):2857-67. doi: 10.1007/s11095-014-1382-7. Epub 2014 Sep 11. Pharm Res. 2014. PMID: 25208873

6

Improved biological properties and hypouricemic effects of uricase from Candida utilis loaded in novel alkaline enzymosomes.

Tan QY, Zhang JQ, Wang N, Yang H, Li X, Xiong HR, Wu JY, Zhao CJ, Wang H, Yin HF. Tan QY, et al. Among authors: xiong hr. Int J Nanomedicine. 2012;7:3929-38. doi: 10.2147/IJN.S33835. Epub 2012 Jul 23. Int J Nanomedicine. 2012. PMID: 22915844 Free PMC article.

7

Nanosomal Microassemblies for Highly Efficient and Safe Delivery of Therapeutic Enzymes.

Xiong H, Zhou Y, Zhou Q, He D, Wan S, Tan Q, Zhang M, Deng X, Zhang J. Xiong H, et al. ACS Appl Mater Interfaces. 2015 Sep 16;7(36):20255-63. doi: 10.1021/acsami.5b05758. Epub 2015 Sep 1. ACS Appl Mater Interfaces. 2015. PMID: 26325262

8

Uricase from Bacillus fastidious loaded in alkaline enzymosomes: enhanced biochemical and pharmacological characteristics in hypouricemic rats.

Tan Q, Zhang J, Wang N, Li X, Xiong H, Teng Y, He D, Wu J, Zhao C, Yin H, Zhang L. Tan Q, et al. Eur J Pharm Biopharm. 2012 Sep;82(1):43-8. doi: 10.1016/j.ejpb.2012.06.002. Epub 2012 Jun 15. Eur J Pharm Biopharm. 2012. PMID: 22705639

9

Nanocapsule assemblies as effective enzyme delivery systems against hyperuricemia.

Xiong H, Zhou Y, Zhou Q, He D, Deng X, Sun Q, Zhang J. Xiong H, et al. Nanomedicine. 2016 Aug;12(6):1557-66. doi: 10.1016/j.nano.2016.02.010. Epub 2016 Mar 21. Nanomedicine. 2016. PMID: 27013130

10

Uricase alkaline enzymosomes with enhanced stabilities and anti-hyperuricemia effects induced by favorable microenvironmental changes.

Zhou Y, Zhang M, He D, Hu X, Xiong H, Wu J, Zhu B, Zhang J. Zhou Y, et al. Sci Rep. 2016 Jan 29;7:20136. doi: 10.1038/srep20136. Sci Rep. 2016. PMID: 26823332 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters